Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kevin Leslie

Anatomic Pathology & Clinical Pathology Phoenix, AZ Medical Doctor

NPI 1386626257 CMS profile 801124

424 S 56Th St Ste 120, Phoenix, AZ 85034

Open in the dashboard

General payments

$206,332

52 records reported · program years 2019–2025

Research payments

$565

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kevin Leslie of Phoenix, AZ is reported in the CMS Open Payments database as having received $206,332 across 52 general payments and $565 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anatomic Pathology & Clinical Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 Research $565 1
2023 General $3,332 3
2022 General $32,045 17
2021 General $91,864 14
2020 General $78,942 17
2019 General $148 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Leslie
  • Anatomic Pathology & Clinical Pathology median
  • Middle half of Anatomic Pathology & Clinical Pathology
  • National median

In program year 2025, general payments to Kevin Leslie were reported at $0. Among 2,804 Anatomic Pathology & Clinical Pathology profiles paid that year, the median was $51 and the middle half received between $24 and $149.

Show as a table
Year Kevin Leslie Anatomic Pathology & Clinical Pathology median Middle half National median
2019 $148 $65 $22–$150 $163
2020 $78,942 $44 $19–$144 $114
2021 $91,864 $42 $19–$142 $132
2022 $32,045 $54 $20–$140 $149
2023 $3,332 $60 $23–$157 $160
2024 $0 $51 $23–$145 $164
2025 $0 $51 $24–$149 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genentech, Inc. $206,183 51 payments
  2. Grifols USA, LLC $148 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $186,866 14 payments
  2. Travel and Lodging $18,284 27 payments
  3. Food and Beverage $1,181 11 payments
Products named General payments · program years 2019–2025
  1. TECENTRIQ $3,332 3 payments
  2. Prolastin-C $148 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Genentech, Inc. $565 1 payment

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anatomic Pathology & Clinical Pathology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record